Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Lantern Pharma Inc.

NASDAQ: LTRN · Life Sciences · 4 alerts · CIK 1763950

Share price
$0.3890Close, Nov 16
Market cap
$4.97M
Shares outstanding
12.78MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Lantern Pharma Inc. filings on SEC EDGAR ↗

4:01 PM ET 8-K
Nasdaq/NYSE Compliance Notice

Lantern Pharma Nasdaq/NYSE Compliance Notice

Lantern Pharma Inc. received a deficiency notice from Nasdaq on September 25, 2026, for failing to maintain a minimum market value of listed securities (MVLS) of $35 million for 30 consecutive business days. The company has 180 calendar days, or until March 24, 2027, to regain compliance by maintaining an MVLS of at least $35 million for 10 consecutive business days.

Counterparty
Nasdaq
Term
180 days
4:05 PM ET 8-K
Capital Raise

Lantern Pharma Capital Raise of $4M

Lantern Pharma Inc. entered into a securities purchase agreement for a registered direct offering of 1,469,725 common shares and 2,200,000 pre-funded warrants at $1.09 per share. The offering raised approximately $4 million in gross proceeds, with a concurrent private placement of warrants that could provide an additional $4 million if fully exercised. The company intends to use the proceeds for working capital and general corporate purposes.

Value
$4M
Counterparty
institutional investor
6:02 AM ET 8-K
Investor Presentation

Lantern Pharma Investor Presentation

Lantern Pharma hosted a live webinar and filed a formal presentation deck (Exhibit 99.1) to discuss its Open-Medicine AI multi-agentic platform for drug development. The presentation highlights the company's AI-driven approach to drug discovery and development, specifically focusing on the Open-Medicine AI platform.

7:46 AM ET 8-K
Investor Presentation

Lantern Pharma Investor Presentation

Lantern Pharma is hosting a live webinar and investor presentation to discuss the growth plan, development roadmap, and economics of its wholly owned subsidiary, Open-Medicine AI. The session will include a live demonstration of the multi-agentic AI platform's capabilities and an overview of the subscription and enterprise licensing model.

Earnings call
Sep 23, 2026, 12:30 PM ET

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.